Amrutanjan Research Development from 2010 to 2024
| AMRUTANJAN | 699.80 4.70 0.67% |
Research Development | First Reported 2010-12-31 | Previous Quarter 11.3 M | Current Value 8.4 M | Quarterly Volatility 4.4 M |
Check Amrutanjan Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amrutanjan Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 35.2 M, Interest Expense of 1.5 M or Total Revenue of 2.3 B, as well as many indicators such as . Amrutanjan financial statements analysis is a perfect complement when working with Amrutanjan Health Valuation or Volatility modules.
Amrutanjan | Research Development |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Amrutanjan Stock
Amrutanjan Health financial ratios help investors to determine whether Amrutanjan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amrutanjan with respect to the benefits of owning Amrutanjan Health security.